Clinical trial

Evaluation of Anhedonia and Emotional Eating in Individuals Using GLP-1 Receptor Agonists

Recruiting now · Not applicable · 1 countries · Registry ID NCT07803185

Recruiting nowNot applicableObservational

What this study is about

This prospective observational study evaluates the longitudinal changes in anhedonia levels and emotional eating behaviors among adult individuals initiating glucagon-like peptide-1 (GLP-1) receptor agonist therapy for weight loss. Participants are assessed at baseline (treatment initiation) and after a 6-month follow-up period using standardized psychometric instruments.

A promising-looking record is not the same as confirmed eligibility. The study team must review the full criteria and current recruitment status.

Basic eligibility

Age18 Years to Not listed

SexAll

Healthy volunteersNot accepted

ConditionObesity, Emotional Eating, Anhedonia

Full registry criteria

Inclusion Criteria: * Age 18 years or older * Newly initiated on GLP-1 receptor agonist treatment for weight reduction * Willingness to participate in evaluations at baseline and at the 6-month follow-up * Ability to read and understand Turkish and possess the cognitive capacity to answer questionnaire items * Voluntary provision of written informed consent Exclusion Criteria: * Use of GLP-1 receptor agonists for indications other than weight loss * Cognitive, neurological, or severe psychiatric conditions preventing completion of self-report questionnaires * Substantial missing, inconsistent, or unverifiable questionnaire data compromising analysis integrity * Non-participation or dropout at the 6-month follow-up evaluation

Treatments and study arms

The registry does not list a named intervention.

Primary outcomes

Change in Dimensional Anhedonia Rating Scale (DARS) ScoreBaseline and 6 months

The DARS is a 17-item self-report questionnaire assessing state anhedonia across four domains (hobbies, food/drink, social activities, and sensory experiences). Each item is scored on a 5-point Likert scale from 0 ("Not at all") to 4 ("Extremely"), yielding a total score between 0 and 68. Lower scores indicate more severe anhedonia.

Study locations

1 locations were listed when this page was built. The first 40 are shown.

Erciyes University Medical Faculty Hospitals, Department of Endocrinology and Metabolism🌐 Kayseri, Melikgazi, Turkey (Türkiye)

Open map

Hasan Durmuş, MD, Assoc. Prof.Contact

Email · Call +90 544 370 6917